Literature DB >> 448091

Two spontaneous BALB/c lymphomas synthesize IgM: monomers and half molecules are isolated and characterized whereas another molecule resembles IgD.

P E McKeever, K J Kim, G B Nero, R Laskov, R M Merwin, W J Logan, R Asofsky.   

Abstract

Spontaneous lymphomas of BALB/c mice, both in vivo tumors and cell lines established in long term tissue cultures, were investigated for their ability to synthesize IgM by using radiolabeled amino acid precursors. Immunoglobulins manufactured by lymphomas K46 and L10A had the m.w. of monomeric IgM and IgM half molecule. Both of these molecules could be immunoprecipitated with class-specific anti-IgM but not anti-IgA or anti-IgG. When precipitated with polyvalent anti-Ig L10A synthesized monomeric immunoglobulins that migrated as two peaks in contrast to their single counterpart precipitated with anti-IgM. The second peak migrated in the region expected for IgD. Monomer and half molecules were composed of similar ratios of mu-chains to light chains linked by disulfide bonds. The mu2L2 monomer of these B cell lines migrated slightly slower in SDS PAGE than a mu2L2 secreted by a myeloma. Thus, these lymphomas synthesize immunoglobulins with the chemical and antigenic characteristics typical of monomeric membrane-attached IgM and IgM half molecules, plus a molecule resembling IgD on L10A only. Lymphoma assembly of monomeric IgM may follow the same initial biosynthetic sequence as myeloma assembly.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448091

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Expression of IgD may use both DNA rearrangement and RNA splicing mechanisms.

Authors:  K W Moore; J Rogers; T Hunkapiller; P Early; C Nottenburg; I Weissman; H Bazin; R Wall; L E Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

2.  Simultaneous expression of mu- and gamma-chain mRNA in cloned murine B-lymphoma cell lines.

Authors:  R Laskov; R Ishay-Michaeli; M Wallach; D Givol; K J Kim
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.